An observational study in Skin Carcinoma, Skin Cancer and Pruritus, sponsored by University Hospital, Brest. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-25.
Sponsored by University Hospital, Brest · Observational
The objective of this study is to have better knowledge about sensations of patients with skin carcinomas and to have data about characteristics of pain and pruritus . All patients presenting with a suspicions lesion for skin carcinomas will be included and will respond to a questionnaire. Demographics data, and histological data about skin carcinomas will be collected.
From 1 April 2015 to 31 July 2015, all patients presenting with a skin lesion suspicious for carcinoma (BCC or SCC) at the Department of Dermatology of the Military Hospital in Brest were included in the study.
all patients with suspected skin carcinoma aged 18 years or more
Exclusion Criteria:
Evaluate characteristics of pruritus in skin carcinomas
Questions about characteristics
Time frame: Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma)
Evaluate characteristics of pruritus in skin carcinomas
Numerical visual scale (EVA)
Time frame: Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Evaluate characteristics of pruritus in skin carcinomas
5D-itch scale
Time frame: Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Evaluate characteristics of pain in skin carcinomas
Numerical visual pain
Time frame: Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Evaluate characteristics of in skin carcinomas
score DN4
Time frame: Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Brest